Gala vs Hims: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats Gala overall, scoring 7.9/10 vs 7/10. Gala is more affordable at $149/mo vs $199/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose Hims for men who want glp-1 access from a well-known, publicly traded.
A side-by-side comparison of Gala and Hims covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaHims
#12 of 42One of the largest and most recognized men's telehealth platforms in the US. In 2026 Hims signed a direct partnership with Novo Nordisk adding FDA-approved brand Wegovy (injection and pill) and Ozempic alongside their existing compounded semaglutide program.
Visit Hims| Feature | Gala | Hims |
|---|---|---|
| Our Score | 7/10 | 7.9/10 |
| Starting Price | $149/mo | $199/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Men who want GLP-1 access from a well-known, publicly traded telehealth brand — now with FDA-approved brand access via the 2026 Novo Nordisk partnership |
| Ranking | #40 | #12 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +2026 Novo Nordisk partnership — FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Polished app and web experience — one of the best user interfaces in men's telehealth
Cons
- −Brand-name pricing jumps to $599/mo for Wegovy injection — not competitive with LillyDirect/NovoCare cash prices
- −Generic support experience — large patient volume means less personalized attention
- −'Hims Oral Kit' is NOT a GLP-1 (it's a non-GLP-1 combo: metformin + bupropion + topiramate + B12 + naltrexone) — easy to confuse with their compounded semaglutide program
- −Higher price than compounded-only competitors like TrimRx or Enhance MD for the same compounded product
Our Verdict
Hims edges out Gala with a score of 7.9/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to Hims's $199/mo. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand — now with fda-approved brand access via the 2026 novo nordisk partnership.